Welcome to Aurore Life Sciences, a specialized pure-play API manufacturer. As a vital link in pharmaceutical drug manufacturing, we are your trusted partner for all your API & Intermediates requirements. Our unwavering commitment to excellence, innovation, and uncompromising quality sets us apart as leaders in Active Pharmaceutical Ingredient (API) production. With a growing legacy, we are dedicated to advancing healthcare through cutting-edge API manufacturing, empowering formulation manufacturers for a future of continued progress and positive impact.
| # | Name of the API | Intermediate Chemical Name | CAS Number |
|---|---|---|---|
| 1 | Acotiamide | Ethyl 2-aminothiazole-4-carboxylate | 5398-36-7 |
| 2 | Amisulpride | 4-Amino-5-(ethylsulfonyl)-2-methoxybenzoic Acid | 71675-87-1 |
| 3 | Amlodipine besylate | 2-[(2-Aminoethoxy)methyl]-4-(2-chlorophenyl)-3-ethoxycarbonyl-5-methoxycarbonyl)-6-methyl-1,4-dihydropyridine (Amlodipine Base) | 88150-62-3 |
| 4 | Amlodipine besylate | 4-(2-Chlorophenyl)-2-[[2-(1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl)ethoxy]methyl]-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylic Acid 3-Ethyl 5-Methyl Ester (Phthaloyl amlodipine) | 88150-42-9 |
| 5 | Bilastine | Methyl 2-(4-(2-chloroethyl)phenyl)-2-methylpropanoate | 1181267-33-3 |
| 6 | Bilastine | 1-(2-Ethoxyethyl)-2-(piperidin-4-yl)-1H-benzo[d]imidazole hydrochloride Sesquihydrate | 1841081-72-8 |
| 7 | Celecoxib | 4-Sulphanamido Phenyl Hydrazine Hydrochloride (4-SAPH) | 17852-52-7 |
| 8 | Celecoxib | 1-(4-Methylphenyl)-4,4,4-Trifluoro-Butane-1,3-Dione | 720-94-5 |
| 9 | Clozapine | 8-Chloro-5,10-dihydro-11H-dibenzo[b, e] [1,4] diazepin-11-one | 50892-62-1 |
| 10 | Clozapine | 2-(2-Amino-4-chlorophenylamino)benzoic acid | 67990-66-3 |
| 11 | Dabigatran | Ethyl 3-[3-Amino-4-(methylamino)-N-(2-pyridyl)benzamido]propionate | 2126144-72-5 |
| 12 | Dabigatran | Hexyl N-[(4-Aminophenyl) iminomethy] carbamate Hydrochloride; | 212322-56-0 |
| 13 | Dabigatran | N-(4-Cyanophenyl)glycine | 1307233-93-7 |
| 14 | Dabigatran | Dabigatran ethyl ester | 429658-95-7 |
| 15 | Dapagliflozin | 5-Bromo-2-chlorobenzoic acid | 21739-92-4 |
| 16 | Dapagliflozin | (5-Bromo-2-chlorophenyl)(4- ethoxyphenyl) methanone | 461432-22-4 |
| 17 | Dapagliflozin | 4-bromo-1-chloro-2-(4-ethoxybenzy!) benzene | 461432-23-5 |
| 18 | Dapagliflozin | (2R,3R,4R,5S,6S)-2-(acetoxymethyl)-6- (4-chloro-3-(4-ethoxybenzyl)phenyl) tetrahydro-2H-pyran-3,4,5-triyl triacetate (Dapa Acetate) | 461432-25-7 |
| 19 | Dapagliflozin & Empagliflozin | (3R,4S,5R,6R)-3,4,5- tris((trimethylsily!)oxy)-6- (((trimethylsilyl)oxy)methyl)tetrahydro- 2H-pyran-2-one | 32384-65-9 |
| 20 | Darunavir | 4-Amino-N-((2R,3S)-3-amino-2-hydroxy-4-phenylbutyl)-N-isobutylbenzenesulfonamide | 169280-56-2 |
| 21 | Darunavir | tert-Butyl ((2R,3R)-4-(4-acetamido-N-isobutylphenylsulfonamido)-3-hydroxy-1-phenylbutan-2-yl) carbamate | 2126144-72-5 |
| 22 | Dolutegravir Sodium | (4R,12aS)-7-Methoxy-4-methyl-6,8- dioxo-3,4,6,8,12,12a-hexahydro-2H- pyrido[1',2':4,5]pyrazino[2,1- b][1,3]oxazine-9-carboxylic Acid | 1335210-34-8 |
| 23 | Dolutegravir Sodium | (4S,12aR)-N-[(2,4-Difluorophenyl) methyl]-3,4,6,8,12,12a-hexahydro-7- methoxy-4-methyl-6,8-dioxo-2H-pyrido [1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9- carboxamide | 1335210-35-9 |
| 24 | Dolutegravir Sodium | (4R,12aS)-9((2,4-diflurobenzyl) carbamoyl)-4- methyl-6,8-dioxo- 3,4,6,8,12,12a-hexahydro-2H- pyrido [1,2,4,5] pyrazino [2, I-b] [1,3] oxazin-7- olate / Dolutegravir free base | 1051375-16-6 |
| 25 | Dronedarone | (4-(3-(dibutylamino)propoxy)phenyl)(2- butyl-5-nitrobenzofuran-3-yl)methanone | 141645-23-0 |
| 26 | Dronedarone | (2-Butyl-5-nitrobenzofuran-3-yl)(4- hydroxyphenyl)methanone | 141645-16-1 |
| 27 | Empagliflozin | (S)-3-(4-(5-bromo-2-chlorobenzyl) phenoxy)tetrahydrofuran | 915095-89-5 |
| 28 | Empagliflozin | (S)-(+)-3-hydroxy-tetrahydrofuran | 86087-23-2 |
| 29 | Empagliflozin | (5-bromo-2-chlorophenyl)-(4- fluorophenyl)methanone | 915095-85-1 |
| 30 | Empagliflozin | (2,3,4,6-Tetra-O-acetyl-1-C-(4-chloro-3-{4-[(3S)-tetrahydrofuran-3-yloxy]benzyl)benzene base)-8-D-glucopyranose (Empa Acetate) | 915095-99-7 |
| 31 | Empagliflozin | (3S)-3-[4-[(2-Chloro-5-lodophenyl)methyl] phenoxy]-tetrahydrofuran (Empa Iodo) | 915095-94-2 |
| 32 | Levothyroxine Sodium | 3,5-Diiodo-Lthyronine | 1041-01-6 |
| 33 | Levothyroxine Sodium | 3,5-Diiodo-L-tyrosine dihydrate | 18835-59-1 |
| 34 | Linagliptin | 8-Bromo-7-(but-2-yn-1-yl)-3-methyl-3,7-dihydro-1H-purine-2,6-dione | 666816-98-4 |
| 35 | Linagliptin | 8-Bromo-7-(but-2-yn-1-yl)-3-methyl-1-((4-methyl quinazolin-2-yl)methyl)-3,7-dihydro-1H-purine-2,6-dione | 853029-57-9 |
| 36 | Linagliptin | Tert-butyl N-[(3R)-piperidin-3-yl]carbamate | 309956-78-3 |
| 37 | Linagliptin | Tert-butyl N-[(3R)-1-[7-but-2-ynyl-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]-2,6-dioxopurin-8-yl]piperidin-3-yl]carbamate (Boc-Lingaliptin) | 668273-75-4 |
| 38 | Loratidine | 8 Chloro-11-[(N-methyl)-4-piperidylidene]-6,11-dihydro-5H-benzo[5,6]cyclohepta (1,2b) Pyridine (Methyl Loratadine) | 38092-89-6 |
| 39 | Marbofloxacin | 6,7,8-trifluoro-1-(formylmethylamino)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid ethyl ester | 100276-65-1 |
| 40 | Nafamostat mesylate | 4-Guanidino benzoic acid hydrochloride (PGBA) | 42823-46-1 |
| 41 | Nafamostat mesylate | 6-Amidino-2-naphthol methane sulfonate (NFT-III) | 82957-06-0 |
| 42 | Olopatadine | 2-(11-Oxo-6,11-dihydrodibenzo[b,e]oxepin-2-yl)acetic acid (Keto Acid) | 55453-87-7 |
| 43 | Olopatadine | 3-chloro-N,N-dimethylpropan-1-amine | 109-54-6 |
| 44 | Pablociclib | Tert-butyl 4-(6-aminopyridin-3-yl)piperazine-1-carboxylate | 571189-16-7 |
| 45 | Pablociclib | 2-chloro-8-cyclopentyl-5-Methylpyrido[2,3-d]pyrimidin-7(8H)-one | 1013916-37-4 |
| 46 | Pinaverium Bromide | 2-Bromo-4,5-dimethoxy benzyl bromide | 53207-00-4 |
| 47 | Pinaverium Bromide | 2-(2-(6,6-dimethylbicyclo[3.1.1]haotan 2-yl)ethoxy)ethyl)morpholine | 38284-47-8 |
| 48 | Pitavastatin | tert-Butyl (4R-cis)-6-formaldehyde-2,2-dimethyl-1,3-dioxane-4-acetate (FDDA) | 124752-23-4 |
| 49 | Prazosin Hydrochloride | 1-(2-Furoyl)piperazine 40172-95-0 | 40172-95-0 |
| 50 | Raloxifene Hydrochloride | Methyl 4-(2-(piperidin-1-yl)ethoxy)benzoate | 89407-97-6 |
| 51 | Raloxifene Hydrochloride | 4-(2-Piperidinoethoxy)benzoic acid hydrochloride | 84449-80-9 |
| 52 | Ramelteon | Diethyl cyanomethylphosphonate | 2537-48-6 |
| 53 | Ramelteon | (1, 6,7,8-Tetrahydro-2H-indeno-[5,4-b]furan-8-ylidene)-acetonitrile | 196597-79-2 |
| 54 | Ramelteon | 2-((S)-2,6,7,8-tetrahydro-1H-indeno[5,4-b]furan-8-yl)ethanamine-ibuprofen salt | NA |
| 55 | Rebamipide | 2-Amino-3-(1,2-dihydro-2-oxoquinoline-4-yl)propanoic acid | 132210-24-3 |
| 56 | Rebamipide | Diethylacetamido malonate | 1068-90-2 |
| 57 | Rebamipide | 4-Bromomethyl 2,2-dihydroquinoline-2- 1 | 1087239 |
| 58 | Risperidone | 6-Fluoro-3-(4-Piperidinyl)1,2-Benzisoxazole Hydrochloride (RS1) | 84163-13-3 |
| 59 | Risperidone | 3-(2-Chloroethyl)-2-Methyl-6,7,8,9-Tetrahydro-4H-Pyrido-(1,2-A)Pyridine-4-One Hydrochloride (RS2) | 93076-03-0 |
| 60 | Risperidone | 2,4-Difluorophenyl-(4-piperidinyl)methanone oxime Hydrochloride | 135634-18-3 |
| 61 | Sacubitril Valsartan | N-[(1R)-2-[1,1'-Biphenyl]-4-yl-1-(hydroxymethyl)ethyl]carbamic acid 1,1-dimethylethyl ester | 149690-05-1 |
| 62 | Sacubitril Valsartan | (2R,4S)-2-Methyl-4-[(2-methylpropan-2-yl)oxycarbonylamino]-5-(4-phenylphenyl)pentanoic Acid | 1426129-50-1 |
| 63 | Sacubitril Valsartan | (2R,4S)-4-[(3-Carboxy-1-oxopropyl)amino]-4-[(p-phenylphenyl)methyl]-2-methylbutanoic Acid Ethyl Ester (Sacubitril) | 1012341-50-2 |
| 64 | Sacubitril Valsartan | sodium; 4-[[(2S,4R)-5-ethoxy-4-methyl-5-oxo-1-(4-phenylphenyl)pentan-2-yl)amino]-4-oxobutanoate (Sacubitril sodium salt) | 149709-62-6 |
| 65 | Sacubitril Valsartan | (2R,4S)-4-[(3-Carboxy-1-oxopropyl)amino]-4-[(p-phenylphenyl)methyl]-2-methylbutanoic Acid Ethyl Ester (Sacubitril) | 132210-24-3 |
| 66 | Sitagliptin | 3-(Trifluoromethyl)-5,6,7,8-tetrahydrotriazolopyrazine Hydrochloride (SIP-III) | 1068-90-2 |
| 67 | Sitagliptin | 1-[3-(Trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazine-7 (8H)-yl]-4-(2,4,5-trifluorophenyl)butane-1,3-dione (SIF-I) | 1087239 |
| 68 | Sodium Cromoglycate | 2,6 Dihydroxyacetophenone | 84163-13-3 |
| 69 | Sulindac | 2-(5-Fluoro-2-methyl-1H-inden-3-yl)acetic acid (SDC-III) | 32004-67-4 |
| 70 | Sulindac | 6-fluoro-2,3-dihydro-2-methylinden-1-one (SDC-l) | 32004-66-3 |
| 71 | Sulindac | 2-(4-fluorobenzyl)propanoic acid (FBPA-II) | 37794-19-7 |
| 72 | Sulindac | 2-((1Z)-1-(4-(Methyl thio)benzylidene)-5-fluoro-2-methyl-1H-inden-3yl)acetic acid (SDC-IV) | NA |
| 73 | Sulindac | 3-(4-fluorophenyl)-2-methylacrylic acid (FBPA-I) | 22138-72-3 |
| 74 | Tafamidis | 4-(3,5-dichlorobenzamido)-3-hydroxybenzoic acid | 1184581-58-5 |
| 75 | Tafamidis | 2-(3,5-dichlorophenyl)-1,3-benzoxazole-6-carboxylic acid (Tafamidis Tech) | 594839-88-0 |
| 76 | Tegoprazan | 4-Hydroxy-N,N,2-trimethyl-1-tosyl-1LH-benzo[d]imidazole-6-carboxamide | 942195-86-0 |
| 77 | Tegoprazan | (R)-5,7-Difluorochroman-ol | 1270294-05-7 |
| 78 | Tofacitinib citrate | 2,4-Dichloro-7H-pyrrolo[2,3-d]pyrimidine | 3680-69-1 |
| 79 | Tofacitinib citrate | (3R,4R)-1-Benzyl-N,4-Dimethylpiperidin-3-amine di hydrochloride | 90213-66-4 |
| 80 | Tofacitinib citrate | bis-(3R,4R)-(1-benzyl-4-methylpiperidine-3-yl)-methylamine di-p-toluoyl-L-tartaric acid | 1062580-52-2 |
| 81 | Tofacitinib citrate | 4-Chloro-7H-pyrrolo[2,3-d]pyrimidine | 477600-71-8 |
| 82 | Tolvaptan | 7-Chloro-3,4-dihydro-1H-benzo[b]azepin-5(2H)-one | 160129-45-3 |
| 83 | Tolvaptan | 7-Chloro-1-(2-methyl-4-nitrobenzoyl)-3,4-dihydro-1H-benzo[b]azepin-5(2H)-one | 137982-91-3 |
| 84 | Tolvaptan | 1-(4-Amino-2-methylbenzoyl)-7-chloro-3,4-dihydro-1H-benzo[b]azepin-5(2H)-one | 137977-97-0 |
| 85 | Tolvaptan | O-Toluyl chloride / 2-methylbenzoyl chloride | 933-88-0 |
| 86 | Valaciclovir HCl | (2S)-2-((2-amino-6-oxo-1Hpurin-9(6H)-yl)methoxy)-3-hydroxypropyl-2(((benzyloxy)carbonyl)amino)-3-methylbutanoate | 124832-31-1 |
| 87 | Valganciclovir HCl | 2-Amino-9-[[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl]-1,9-dihydro-6H-purin-6-one / Ganciclovir | 82410-32-0 |
| 88 | Valganciclovir HCl | [2-[(2-amino-6-oxo-3H-purin-9-yl)methoxy]-3-hydroxypropyl] acetate / Monoacetyl ganciclovir | 88110-89-8 |
| 89 | Valganciclovir HCl | 2-Benzyloxy carbonylamino-3-methylbutyric acid 2-(2-amino-6-oxo-1,6-dihydro-purin-9-yl methoxy)-3-acetoxy-propyl ester | 194159-22-3 |
| 90 | Valganciclovir HCl | 2-Benzyloxy carbonylamino-3-methylbutyric acid 2-(2-amino-6-oxo-1,6-dihydro-purin-9-yl methoxy)-3-hydroxy-propyl ester | 194154-40-0 |
| 91 | Vildagliptin | (S)-1-(2-chloroacetyl) pyrrolidine-2-carbonitrile | 207557-35-5 |
| 92 | Voriconazole | 4-Chloro-6-ethyl-5-fluoropyrimidine | 137234-74-3 |
| 93 | Edoxaban | tert-Butyl [(1R,2S,5S)-2-[[2-[(5-chloropyridin-2-yl)amino]-2-oxoacetyl]amino]-5-(dimethylaminocarbonyl)cyclohexyl]carbamate (Edoxaban) | 480452-36-6 |
| 94 | Edoxaban | N1-(5-Chloropyridin-2-yl)-N2-((1S,2R,4R)-4-(dimethylcarbamoyl)-2-(5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine-2-carboxamido)cyclohexyl) oxalamide (Edoxaban Base) | 1255529-26-0 |
| 95 | Etoricoxib | 1-(6-methylpyridin-3-yl)-2-(4-(methylsulfonyl)phenyl) ethanone (Etoricoxib - Ketosulfone) | 221615-75-4 |
| 96 | Etoricoxib | 2-Chloro-1,3-Bis(Dimethylamino) trimethinium hexa flouro phosphate (Etoricoxib - Sodium hexa flouro phosphate) | 291756-75-8 |
| 97 | Fesoterodine fumarate | 2-[3-[di(propan-2-yl)amino]-1-phenylpropyl]-4-(hydroxymethyl)phenol (Fesoterodine fumarate) | 200801-70-3 |
| 98 | Fesoterodine fumarate | 2-0x0-4-phenyl-3,4-dihydrochromene-6-carboxylic acid (Fesoterodine fumarate) | 356782-33-7 |
| 99 | Fesoterodine fumarate | Methyl 2-oxo-4-phenyl-3,4-dihydrochromen-6-carboxylate (Fesoterodine fumarate) | 380636-42-0 |
| 100 | Fesoterodine fumarate | 6-(hydroxy methyl)-4-phenyl-3,4-dihydro-2h-chromen-2-ol (Fesoterodine fumarate) | 959624-24-9 |
| 101 | Fimasatran | 2-(2-butyl-4-methyl-6-oxo-1-[[4-[2-(1-trityltetrazol-5-yl)phenyl]phenyl]methy!] pyrimidin-5-yl)-N,N-dimethylacetamide (Fimasartan) | 503155-67-7 |
| 102 | Flecanaide Acetate | 2,5-Bis(trifluoroethoxy)benzoic acid (Flecanaide Acetate) | 35480-52-5 |
| 103 | Flecanaide Acetate | N-(piperidin-2-ylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)benzamide (Flecanide Base) | 54143-55-4 |
| 104 | Ganciclovir | 1,3-Dichloro-2-(methoxymethoxy)propane | 70905-45-2 |
| 105 | Ganciclovir | 1,3-Diacetoxy-2-(acetoxy methoxy)propane (Ganciclovir) | 86357-13-3 |
| 106 | Ganciclovir | 1,3-Diacetoxy-2-(methoxymethoxy)propane | 103824-51-7 |
| 107 | Zaltoprofen | 5-(1-Carboxyethyl)-2-(phenylthio)phenylacetic acid | 83237-49-4 |
Quality is the cornerstone of our operations. Our stringent quality control measures ensure that each API is manufactured to the highest standards, fostering trust and confidence in our partners and end-users alike.
Embracing innovation, we constantly push the boundaries of API manufacturing. Our research and development teams collaborate seamlessly to create cutting- edge solutions that address the evolving needs of the pharmaceutical industry.
We adhere to rigorous regulatory guidelines across all phases of production. Our commitment to compliance guarantees that every API leaving our facilities is safe, reliable, and ready for integration into pharmaceutical formulations.
At Aurore Life Sciences, we view our clients as partners on a shared journey. Our collaborative approach ensures that we understand your unique requirements, enabling us to tailor our services to your specific needs.
With a global footprint, we are strategically positioned to serve clients worldwide while maintaining a localized and personalized touch in all interactions.